Dexmedetomidine Protects Against Septic Liver Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT1 Signaling Pathway

Dexmedetomidine Protects Against Septic Liver Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT1 Signaling Pathway

Background: Liver injury is one of the serious complications of sepsis. Previous studies suggested that dexmedetomidine (DEX) could alleviate cecal ligation and puncture (CLP)-induced liver injury. However, it is unclear whether the protective effect of DEX on sepsis-induced liver injury is related...

Full description

Bibliographic Details
Main Authors: Qing Yu, Liying Zou, Xiu Yuan, Fang Fang, Feng Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
sepsis
liver injury
dexmedetomidine
autophagy
clp
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.658677/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.658677/full

Similar Items